Click the image to download/view MADRAC Bulletin – Dec 2015.
- Succinylated Gelatin Intravenous Infusion Products - Summary of Safety Review in 2015
- Amlodipine: Possible Risk of Blurred Vision
- Cardiovascular Adverse Events Related to Diclofenac
- Direct Healthcare Professional Communications (DHPCs) Reviewed and Approved by NPCB in 2015
- Montelukast: Risk of Thrombocytopenia
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Risk of Severe Joint Pain
- Fusafungine: Risk of Serious Allergic Reactions
- New and Improved ADR Reporting Form (Blue Form)
- ADR Reports Involving Anti-Tuberculosis Drugs
|